The role of α-tocopherol in preventing disease: From epidemiology to molecular events

Molecular Aspects of Medicine

Volumn 24, Issue 6, 2003, Pages 325-336

  Azzi, A ^a   Gysin, R ^a   Kempna P ^a   Ricciarelli, R ^b   Villacorta, L ^a   Visarius, T ^a   Zingg, J M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cell signaling; Gene expression; Non antioxidant; Protein kinase C; Tocopherols; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL TRANSFER PROTEIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; CARRIER PROTEIN; CD36 ANTIGEN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOOXYGENASE 2; CYTOKINE; FREE RADICAL; INTERSTITIAL COLLAGENASE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NUCLEIC ACID; OXIDIZING AGENT; PROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; STATIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ALPHA TOCOPHEROL DEFICIENCY; ATAXIA; ATHEROSCLEROSIS; CANCER PREVENTION; CARDIOVASCULAR SYSTEM; CELL CYCLE; CELL PROLIFERATION; CHEMICAL INTERACTION; COLORECTAL CARCINOMA; DIET SUPPLEMENTATION; EPIDEMIOLOGICAL DATA; FIBROGENESIS; FRIEDREICH ATAXIA; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MOLECULAR BIOLOGY; MOLECULE; NONHUMAN; OSTEOSARCOMA; PATHOPHYSIOLOGY; PROPHYLAXIS; PROSTATE CANCER; PROSTATE CARCINOMA; PROTECTION; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; RNA STABILITY; STROKE; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; VITAMIN INTAKE;

EID: 0142185250     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(03)00028-1     Document Type: Review

References (95)

1. Akeson A.L., Woods C.W., Mosher L.B., Thomas C.E., Jackson R.L. Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis. 86:1991;261-270.
2. Albanes D., Heinonen O.P., Huttunen J.K., Taylor P.R., Virtamo J., Edwards B.K., Haapakoski J., Rautalahti M., Hartman A.M., Palmgren J. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-tocopherol Beta-carotene Cancer Prevention Study. Am. J. Clin. Nutr. 62:1995;1427S-1430S.
3. Andersson S.O., Baron J., Bergstrom R., Lindgren C., Wolk A., Adami H.O. Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidem. Biomar. Prev. 5:1996;509-513.
4. Aratri E., Spycher S.E., Breyer I., Azzi A. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett. 447:1999;91-94.
5. Astley S., Langrish-Smith A., Southon S., Sampson M. Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care. 22:1999;1626-1631.
6. Azzi A., Aratri E., Boscoboinik D., Clement S., Ozer N.K., Ricciarelli R., Spycher S. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors. 7:1998;3-14.
7. Azzi A., Breyer I., Feher M., Ricciarelli R., Stocker A., Zimmer S., Zingg J. Nonantioxidant functions of alpha-tocopherol in smooth muscle cells. J. Nutr. 131:2001;378S-381S.
8. Azzi A., Gysin R., Kempnà P., Ricciarelli R., Villacorta L., Visarius T., Zingg J.M. Regulation of gene and protein expression by vitamin E. Free Radical Res. 36:2002;30-36.
9. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 519:2002;8-10.
10. Ban R., Takitani K., Kim H.-S., Murata T., Morinobu T., Ogihara T., Tamai H. α-Tocopherol transfer protein expression in rat liver exposed to hyperoxia. Free Radical Res. 36:2002;933-938.
11. Ben Hamida C., Doerflinger N., Belal S., Linder C., Reutenauer L., Dib C., Gyapay G., Vignal A., Le Paslier D., Cohen D. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat. Genet. 5:1993;195-200. see comments.
12. Blatt D.H., Leonard S.W., Traber M.G. Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition. 17:2001;799-805.
13. Boscoboinik D., Szewczyk A., Azzi A. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286:1991;264-269.
14. Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266:1991;6188-6194.
15. Boscoboinik D., Özer N.K., Moser U., Azzi A. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Arch. Biochem. Biophys. 318:1995;241-246.
16. Breyer I., Azzi A. Differential inhibition by alpha- and beta-tocopherol of human erythroleukemia cell adhesion: role of integrins. Free Radical Biol. Med. 30:2001;1381-1389.
17. Brigelius-Flohe R., Traber M.G. Vitamin E: function and metabolism. FASEB J. 13:1999;1145-1155.
18. Cachia O., Benna J.E., Pedruzzi E., Descomps B., Gougerot-Pocidalo M.A., Leger C.L. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J. Biol. Chem. 273:1998;32801-32805.
19. Cachia O., Leger C.L., Descomps B. Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein. Atherosclerosis. 138:1998;263-269.
20. Carr A.C., Zhu B.Z., Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha- tocopherol (vitamin E). Circ. Res. 87:2000;349-354.
21. Chang S.J., Lin J.S., Chen H.H. Alpha-tocopherol downregulates the expression of GPIIb promoter in HEL cells. Free Radical Biol. Med. 28:2000;202-207.
22. Chatelain E., Boscoboinik D.O., Bartoli G.M., Kagan V.E., Gey F.K., Packer L., Azzi A. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta. 1176:1993;83-89.
23. Chojkier M., Houglum K., Lee K.S., Buck M. Long- and short-term D-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression. Am. J. Physiol. 275:1998;G1480-G1485.
24. Cynshi O., Kawabe Y., Suzuki T., Takashima Y., Kaise H., Nakamura M., Ohba Y., Kato Y., Tamura K., Hayasaka A., Higashida A., Sakaguchi H., Takeya M., Takahashi K., Inoue K., Noguchi N., Niki E., Kodama T. Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc. Natl. Acad. Sci. USA. 95:1998;10123-10128.
25. Eichholzer M., Stahelin H.B., Ludin E., Bernasconi F. Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective basel study. Prostate. 38:1999;189-198.
26. Fazzio A., Marilley D., Azzi A. The effect of alpha-tocopherol and beta-tocopherol on proliferation, protein kinase C activity and gene expression in different cell lines. Biochem. Mol. Biol. Int. 41:1997;93-101.
27. Fischer A., Pallauf J., Gohil K., Weber S.U., Packer L., Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem. Biophys. Res. Commun. 285:2001;470-475.
28. Freedman J.E., Farhat J.H., Loscalzo J., Keaney J.F. Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation. 94:1996;2434-2440.
29. Gann P.H., Ma J., Giovannucci E., Willett W., Sacks F.M., Hennekens C.H., Stampfer M.J. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59:1999;1225-1230.
30. Giovannucci E. Gamma-tocopherol: a new player in prostate cancer prevention. J. Natl. Cancer Inst. 92:2000;1966-1967.
31. Gysin R., Azzi A., Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 16:2002;1952-1954.
32. Haidari M., Javadi E., Kadkhodaee M., Sanati A. Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clin. Chem. 47:2001;1234-1240.
33. Hayes R.B., Bogdanovicz J.F., Schroeder F.H., De Bruijn A., Raatgever J.W., Van der Maas P.J., Oishi K., Yoshida O. Serum retinol and prostate cancer. Cancer. 62:1988;2021-2026.
34. Heinecke J.W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler. Thromb. Vasc. Biol. 21:2001;1261-1264.
35. Heinonen O.P., Albanes D., Virtamo J., Taylor P.R., Huttunen J.K., Hartman A.M., Haapakoski J., Malila N., Rautalahti M., Ripatti S., Maenpaa H., Teerenhovi L., Koss L., Virolainen M., Edwards B.K. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Inst. 90:1998;440-446.
36. Helzlsouer K.J., Huang H.Y., Alberg A.J., Hoffman S., Burke A., Norkus E.P., Morris J.S., Comstock G.W. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J. Natl. Cancer Inst. 92:2000;2018-2023.
37. Hoogwerf B.J., Young J.B. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Clev. Clin. J. Med. 67:2000;287-293.
38. Hoppe P.P., Krennrich G. Bioavailability and potency of natural-source and all-racemic alpha-tocopherol in the human: a dispute. Eur. J. Nutr. 39:2000;183-193.
39. Houglum K., Venkataramani A., Lyche K., Chojkier M. A pilot study of the effects of D-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology. 113:1997;1069-1073.
40. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals a randomised placebo-controlled trial. Lancet. 360:2002;23-33.
41. Hsing A.W., Comstock G.W., Abbey H., Polk B.F. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J. Natl. Cancer Inst. 82:1990;941-946.
42. Huang H.Y., Alberg A.J., Norkus E.P., Hoffman S.C., Comstock G.W., Helzlsouer K.J. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am. J. Epidemiol. 157:2003;335-344.
43. Ingold K.U., Bowry V.W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:1993;45-49.
44. Jialal I., Fuller C.J. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can. J. Cardiol. 11(Suppl G):1995;97G-103G.
45. Jialal I., Devaraj S., Kaul N. The effect of alpha-tocopherol on monocyte proatherogenic activity. J. Nutr. 131:2001;389S-394S.
46. Jialal I., Traber M., Devaraj S. Is there a vitamin E paradox? Curr. Opin. Lipidol. 12:2001;49-53.
47. Kempnà P., Zingg J.M., Ricciarelli R., Hierl M., Saxena S., Azzi A. Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radical Biol. Med. 34:2003;1458-1472.
48. Kolleck I., Schlame M., Fechner H., Looman A.C., Wissel H., Rustow B. HDL is the major source of vitamin E for type II pneumocytes. Free Radical Biol. Med. 27:1999;882-890.
49. Landes N., Pfluger P., Birringer M., Brigelius-Flohé R. Vitamin E activates hPXR-mediated gene expression in HEPG2 cells. Free Radical Biol. Med. 33:2002;S189.
50. Liu J.F., Lee Y.W. Vitamin C supplementation restores the impaired vitamin E status of guinea pigs fed oxidized frying oil. J. Nutr. 128:1998;116-122.
51. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol. Res. 40:1999;227-238.
52. Marchioli R., Valagussa F. The results of the GISSI-prevenzione trial in the general framework of secondary prevention. Eur. Heart J. 21:2000;949-952.
53. Meydani M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J. Nutr. 131:2001;366S-368S.
54. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Siber G., Loszewski R., Thompson C., Pedrosa M.C., Diamond R.D., Stollar B.D. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA. 277:1997;1380-1386.
55. Niki E. Interaction of ascorbate and alpha-tocopherol. Ann. N.Y. Acad. Sci. 498:1987;186-199.
56. Nomura A.M., Ziegler R.G., Stemmermann G.N., Chyou P.H., Craft N.E. Serum micronutrients and upper aerodigestive tract cancer. Cancer Epidemiol. Biomar. Prev. 6:1997;407-412.
57. Özer N.K., Sirikci O., Taha S., San T., Moser U., Azzi A. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radical Biol. Med. 24:1998;226-233.
58. Packer L. Interactions among antioxidants in health and disease: vitamin E and its redox cycle. Proc. Soc. Exp. Biol. Med. 200:1992;271-276.
59. Packer L., Weber S.U., Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J. Nutr. 131:2001;369S-373S.
60. Podda M., Tritschler H.J., Ulrich H., Packer L. Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem. Biophys. Res. Commun. 204:1994;98-104.
61. Porter T.D. Supernatant protein factor and tocopherol-associated protein: an unexpected link between cholesterol synthesis and vitamin E (review). J. Nutr. Biochem. 14:2003;3-6.
62. Pruthi S., Allison T.G., Hensrud D.D. Vitamin E supplementation in the prevention of coronary heart disease. Mayo Clin. Proc. 76:2001;1131-1136.
63. ′-deiodinase activity in cultured glial and fibroblastic cells from the cerebella of newborn rats. Horm. Metab. Res. 31:1999;591-596.
64. Ricciarelli R., Maroni P., Ozer N., Zingg J.M., Azzi A. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radical Biol. Med. 27:1999;729-737.
65. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation. 102:2000;82-87.
66. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E 80th anniversary: a double life, not only fighting radicals. IUBMB Life. 52:2001;71-76.
67. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J. 15:2001;2314-2325.
68. Rohan T.E., Howe G.R., Burch J.D., Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control. 6:1995;145-154.
69. Salonen J.T., Nyyssonen K., Salonen R., Lakka H.M., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Lakka T.A., Rissanen T., Leskinen L., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Poulsen H.E. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Int. Med. 248:2000;377-386.
70. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Lakka H.M., Vanharanta M., Salonen J.T., Poulsen H.E. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation. 107:2003;947-953.
71. Sato Y., Hagiwara K., Arai H., Inoue K. Purification and characterization of the alpha-tocopherol transfer protein from rat liver. FEBS Lett. 288:1991;41-45.
72. Schwartz J., Shklar G., Trickler D. p53 in the anticancer mechanism of vitamin E. Eur. J. Cancer B, Oral Oncol. 29B:1993;313-318.
73. Simons L.A., Von Konigsmark M., Balasubramaniam S. What dose of vitamin E is required to reduce susceptibility of LDL to oxidation. Aust. N.Z. J. Med. 26:1996;496-503.
74. Smith D., O'Leary V.J., Darley-Usmar V.M. The role of alpha-tocopherol as a peroxyl radical scavenger in human low density lipoprotein. Biochem. Pharmacol. 45:1993;2195-2201.
75. Staal A., Van Wijnen A.J., Desai R.K., Pols H.A., Birkenhager J.C., Deluca H.F., Denhardt D.T., Stein J.L., Van Leeuwen J.P., Stein G.S., Lian J.B. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology. 137:1996;2001-2011.
76. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1993;1444-1449.
77. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
78. Stocker A., Zimmer S., Spycher S.E., Azzi A. Identification of a novel cytosolic tocopherol-binding protein: structure, specificity, and tissue distribution. IUBMB Life. 48:1999;49-55.
79. Tesoriere L., D'Arpa D., Butera D., Allegra M., Renda D., Maggio A., Bongiorno A., Livrea M.A. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radical Res. 34:2001;529-540.
80. Teupser D., Thiery J., Seidel D. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis. 144:1999;109-115.
81. Traber M.G., Kayden H.J. Alpha-tocopherol as compared with gamma-tocopherol is preferentially secreted in human lipoproteins. Ann. N.Y. Acad. Sci. 570:1989;95-108.
82. Traber M.G., Kayden H.J. Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 49:1989;517-526.
83. Traber M.G., Burton G.W., Hughes L., Ingold K.U., Hidaka H., Malloy M., Kane J., Hyams J., Kayden H.J. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J. Lipid Res. 33:1992;1171-1182.
84. Triantafillidis J.K., Kottaras G., Sgourous S., Cheracakis P., Driva G., Konstantellou E., Parasi A., Choremi H., Samouilidou E. A-beta-lipoproteinemia: clinical and laboratory features, therapeutic manipulations, and follow-up study of three members of a Greek family. J. Clin. Gastroenterol. 26:1998;207-211.
85. Villacorta L., Graca-Souza A.V., Ricciarelli R., Zingg J.M., Azzi A. Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells. Circ. Res. 92:2003;104-110.
86. Vlajinac H.D., Marinkovic J.M., Ilic M.D., Kocev N.I. Diet and prostate cancer: a case-control study. Eur. J. Cancer. 33:1997;101-107.
87. Weiser H., Riss G., Kormann A.W. Biodiscrimination of the eight alpha-tocopherol stereoisomers results in preferential accumulation of the four 2R forms in tissues and plasma of rats. J. Nutr. 126:1996;2539-2549.
88. Wu C.G., Hoek F.J., Groenink M., Reitsma P.H., van Deventer S.J., Chamuleau R.A. Correlation of repressed transcription of alpha-tocopherol transfer protein with serum alpha-tocopherol during hepatocarcinogenesis. Int. J. Cancer. 71:1997;686-690.
89. Wu D., Mura C., Beharka A.A., Han S.N., Paulson K.E., Hwang D., Meydani S.N. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am. J. Physiol. 275:1998;C661-C668.
90. Wu D., Hayek M.G., Meydani S. Vitamin E and macrophage cyclooxygenase regulation in the aged. J. Nutr. 131:2001;382S-388S.
91. Yamauchi J., Iwamoto T., Kida S., Masushige S., Yamada K., Esashi T. Tocopherol-associated protein is a ligand-dependent transcriptional activator. Biochem. Biophys. Res. Commun. 285:2001;295-299.
92. Yokota T., Igarashi K., Uchihara T., Jishage K., Tomita H., Inaba A., Li Y., Arita M., Suzuki H., Mizusawa H., Arai H. Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. USA. 98:2001;15185-15190.
93. Zimmer S., Stocker A., Sarbolouki M.N., Spycher S.E., Sassoon J., Azzi A. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J. Biol. Chem. 275:2000;25672-25680.
94. Zimmer S., Stocker A., Sarbolouki M.N., Spycher S.E., Sassoon J., Azzi A. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J. Biol. Chem. 275:2000;25672-25680.
95. Zingg J.M., Ricciarelli R., Azzi A. Scavenger receptors and modified lipoproteins: fatal attractions? IUBMB Life. 49:2000;397-403.